NEW YORK – Issues of data privacy and patient identifiability have concerned the genomics space for some time now, but new regulations and advancing technical capabilities could force proteomics researchers to confront these questions, as well.
Proteomics Beginning to Grapple With Patient Privacy Questions in Wake of Technology Advances
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.